Semafor
US · 58 mins ago
Eli Lilly tries to stop GLP-1 copycats
Eli Lilly said it filed six lawsuits against US companies it accused of selling illicit versions of its experimental obesity drug retatrutide.
Do you trust Semafor?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!